Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics

Authors

Ábel Nagy, KTH Royal Institute of Technology
David Ulmert, Lund University
Wahed Zedan, Lund University
Claire M Storey, University of California, Los Angeles
Julie Park, University of California, Los Angeles
Susanne Geres, Lund University
Katharina Lückerath, University of Duisburg-Essen
Kjell Sjöström, Innovagen AB
Hadis Westin, Ridgeview AB
Norbert Peekhaus, University of California, Los Angeles
Daniel Lj Thorek, Washington University School of Medicine in St. Louis
Amelie Eriksson Karlström, KTH Royal Institute of Technology
Mohamed Altai, Lund University

Journal

European Journal of Medicinal Chemistry

Publication Date

12-15-2024

Volume

280

First Page

116927

Document Type

Open Access Publication

DOI

10.1016/j.ejmech.2024.116927

Rights and Permissions

Nagy Á, Ulmert D, Zedan W, Storey CM, Park J, Geres S, Lückerath K, Sjöström K, Westin H, Peekhaus N, Thorek DL, Karlström AE, Altai M. Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics. Eur J Med Chem. 2024 Dec 15;280:116927. doi: 10.1016/j.ejmech.2024.116927. © 2024 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Nagy, Ábel; Ulmert, David; Zedan, Wahed; Storey, Claire M; Park, Julie; Geres, Susanne; Lückerath, Katharina; Sjöström, Kjell; Westin, Hadis; Peekhaus, Norbert; Thorek, Daniel Lj; Karlström, Amelie Eriksson; and Altai, Mohamed, "Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics." European Journal of Medicinal Chemistry. 280, 116927 (2024).
https://digitalcommons.wustl.edu/oa_4/5505

Additional Links

Supplemental material is available for this article at publisher site.